The minimal effect of anti-IL-17A treatment on Ccl2 and rather a slightly decreased gene expression of Zc3h12a in lung tissue at day 28 (Fig. 2D,G; Supplementary Fig. S4B), suggest a dispensable role for IL-17A at this stage of the infection. The gene discussed is CCL2; the disease is infection.